pharmaceutical companies in Nigeria
pharmaceutical exporters

Developing Pharmaceutical Industry in Africa

The African pharmaceutical market is developing at a rapid speed due to changing economic profiles, growing investment in healthcare, rapid urbanization, and increase in chronic lifestyle diseases. In 2013, the pharmaceutical industry’s value touched $20.8 billion. Multinational pharma companies got a good chance to boost and expand their business. Also, patients gained access to world-class medicines that were not available earlier.

The tropical climate is responsible for various infectious diseases:

The continent encounters infectious diseases like tuberculosis, malaria, AIDs, polio, cholera, yellow fever, meningitis, pandemic influenza, hepatitis, measles, tetanus, etc. There is a visible shift towards non-communicable diseases due to the growing adoption of western lifestyle in Africa, Nigeria, etc.

The pharmaceutical companies in Nigeria, Africa, etc. are manufacturing and importing generic and prescription drugs from other countries. Certain lifestyle diseases including cancer, cardiovascular ailments, diabetes, etc. are growing at a high rate. According to the prediction of the World Health Organization, the NCDs’ proportional contribution to the healthcare burden in these nations will grow by 21% by 2030.

The transitional phase of Africa and Nigeria:

Currently, the nations are in a transitional phase. They are looking forward and working hard towards adherence to certain global standards like the WHO pre-qualification to manufacture. Local production by the top 20 pharmaceutical companies in Nigeria, Africa, etc. is considered as the main strategy for persistent access to high-quality medicines for the long term.

Again, the regulatory environment for medicine production in East Africa is rapidly growing due to the regional harmonization. Experts are expecting expansion of healthcare coverage to a greater number of people through the initiatives of National Health Insurance and through memberships with providers of Private Health Insurance.

The rising popularity of generic medicines:

Generic drugs are getting more market share in Nigeria, South Africa, Kenya, Algeria, Egypt, and Morocco. Between the year 2010 and 2014, the share of generic drugs’ market raised from 22 to 25 percent in Algeria. In Morocco, the rise was from 23 to 28 percent. The pharmaceutical exporters in Africa are finding various factors.

  • The pharmacists and physicians are getting habituated to prescription drugs.
  • There is an expansion of national insurance programs.
  • Many people are gaining access to modern healthcare.
  • The demands for generic drugs are growing instead of costly branded medicines.
  • Governments are displaying strong support for generic medicines. In South Africa, pharmacists are informing private patients about these medicines while they are buying prescription drugs. Again, Nigeria is also following similar law.

 

The business environment is changing:

Governments have taken various initiatives like introducing price controls, import restrictions to give way to the manufacturing of domestic drugs. Country-specific labelling is required for reduction of parallel imports and counterfeiting. Again, the government has initiated stricter laws on import, retail margins and wholesale.

Pharma manufacture in Nigeria, Africa and other locations is on a steady rise. Several joint ventures, partnerships, merging, strategic alliances and private-equity deals are taking place and expanding the present market.

Presently, South Africa is the most superior region for products of medicines in Sub-Saharan Africa. The local market of pharmaceutical manufacturing in East and West Africa are likely to develop. Majority of Africa-based pharmaceutical firms are producing medicines having simple mixtures and formulations.

Technological development is crucial for the development of the manufacturing sector in Nigeria and Africa mainly due to the change in disease burden. Nowadays, the nations are adopting complex formulations aligning with treatment guidelines related to AIDS, HIV, and NCDs.

Grounds of the pharmaceutical industry in African countries:

The pharmaceutical markets in African countries are growing in all sectors. In the recent past till last year, there was a steady growth of prescription drugs, generic medicines, over the counter medicines and lots of medical devices.

The driving grounds are:

Speedy urbanization: The population of Africa is currently passing through a tremendous shift. It is estimated that by the year 2025, around two-fifth of the total economic growth will arrive from 30 cities that consist of around 2 million people. Again, 22 of these cities can have excess GDP of around $20 billion. These cities are likely to enjoy better healthcare and logistics infrastructure. The urban people have more buying capabilities and they can adopt modern best-in-class medicines.

The infrastructure of healthcare: Africa has added 70,000 hospital beds, 16,000 good doctors and 60,000 trained nurses between 2005 and 2012. The provision of healthcare is becoming more methodical via various initiatives. Moreover, the origination of avant-garde delivery models is boosting the capacity.

African pharma market has a better future:

Africa is not a single unified market. It is consisting of 54 distinct markets embracing wide gaps between countries in respect to a growth trajectory, market size, legal structure, macroeconomic landscape, and political complexities. The number of households interested in consuming world-class medicines is increasing. Hence, the pharmaceutical companies in Nigeria and pharmaceutical exporters in Africa are focusing on providing more quality medicines to all.

Make a Call: +91 9979382527
Mail us at [email protected]

pharmaceutical companies in Qatar
Pharmaceutical Company

Pharmaceutical Companies in Qatar Fulfilling Growing Medicine Demands

A drug or pharmaceutical company refers to a commercial business that is licensed for researching, developing, testing, marketing and distributing medicines to the healthcare sector. These companies deal with both generic and brand medications.  They have to follow a particular set of rules and regulations in relation to testing, patenting, marketing, etc.

The generic medicine supplier has become one of the most influential and profit-making hubs since the beginning of the 19th century. Amidst an array of controversy and praises, the pharma industry has become a necessity for the entire world.

Qatar is shining bright in pharma sphere:

There is a process known as drug discovery that deals with the discovery and designing of drugs. In earlier days, the majority of drugs were used to get discovered by the identification of active ingredients through the source of traditional remedies. Also, there was a serendipitous discovery.

In Middle East, USA, UK, India, etc., a newer approach is being taken to understand the way molecular and physiological level control disease and infection for targeting particular entities. In order to make the process faster, new technologies and systems of informatics and data management have been employed. Development of drugs is intensive and expensive and these countries are coping effectively.

Moreover, the investigation is done on various compounds and their use in humans. Approval has been given to a small fraction. Determining the efficacy and safety of the compounds are possible after pre-clinical development, followed by clinical trials and safety monitoring.

The reputed pharmaceutical companies in Qatar are exporting OTC products, nutraceutical medicines and other pharma products that arrive in various forms of dosage. Usually, pharmaceutical products in Qatar consist of tablets, injections, ointments, drops, syrups, sachets, etc.

Many Indian hubs have their branches in Qatar and other nations in the Middle East. These hubs manufacture many drugs at their in-house facilities in India. The US FDA, GMP, ISO 9001, and WHO-GMP certify these facilities.

Qatar is improving performance:

The pharmaceutical manufacturing companies in Qatar are presently involved in the development of a growing portfolio of excellent formulations in the area of health care. They boast a vision of high quality and affordable drugs, generic medicines, etc. and are growing rapidly into a dynamic group.

Qatar is trying to park its surplus that is investible. Again, a country like India is looking forward at investments for funding the growth based on infrastructure. Both the countries can benefit from it.

The general rules for exporting medicines from India to other countries:

  • Drug license off wholesale or manufacturing
  • Import Export Code
  • Current bank account for receiving payment

Requirements for exporting to Arab countries:

GCC approval is required if the products have to be exported to Qatar, Saudi Arabia, UAE, Oman, Bahrain, and Kuwait. Saudi FDA should inspect and approve the manufacturing facility.

The relation between Qatar and India:

The relation between Qatar and India is historic. It is expected that in the year 2023, both the nations will remember the grand 50th anniversary of diplomatic relation’s establishment. Approximately 7 lakhs Indian people reside in Qatar which is the true backbone of the healthy partnership between both nations.

There is a strong bilateral trade relationship between them. It surpassed USD 11 billion in the year 2019-2020. The dominating trade is energy.

The medicine exporters in Qatar strictly stick to national and International Regulatory Requirements along with producing superior products.

The commitment of pharmaceutical companies in Qatar:

The companies are committed to bring continuous improvement and add values to the quality standards for satisfying the needs of customers.

During the Corona Virus pandemic when most of the planes have been grounded throughout the world, on April 2, Qatar Airways Cargo declared that it has started nineteen weekly flights between India and Doha. The initiative is for receiving goods like Pharmaceutical products.

These flights are focused on imparting quality Indian products that have a strong demand in the Middle East such as fresh produce and medicines.

There is a continuation of strong demand for imports and exports, especially related to the transportation of necessary medical supplies that are produced in India and are needed to fight against Corona Virus.

Generic drug supplier is playing a vital role:

India is a country that supplies approximately 1,000 tonnes of APIs to Europe for paracetamol, a common pain reliever. It eases the export controls on OTC medicines that are used for dealing with symptoms of COVID 19.

India is presently the main generic drug supplier. It has shipped around 1.9 million tablets and certain other forms of paracetamol to thirty-one countries. Again, it has added the consignments of Hydroxychloroquine, the anti-malaria drug and paracetamol to be sent to 87 countries commercially.

Countries like the United Arab Emirates, Russia, Jordan and major partners in Latin America and Africa are likely to export paracetamol and hydroxychloroquine from India. Medicine exporters in Qatar are all ready to strengthen the bond with India further to keep on receiving excellent medicines at the most competitive price.

Make a Call: +91 9979382527
Mail us at [email protected]

Generic Medicine Suppliers
Generic Medicine

Generic Medicine Suppliers Serving as World’s Pharmacy

The need of India to produce a huge amount of generic drugs perfectly lines up with its aim to become the most promising bulk, generic drug exporter, to markets of Africa, Qatar, Thailand, etc. Giving importance to this context, the nation has to embrace the economy and focus on producing bulk drugs to give the toughest competition to China and other countries. The government and the private generic medicine supplier are adopting distinct policy measures to generate new formulations and export bulk drugs.

Pharmaceutical as a component:

The trade expansion strategy of India considers pharmaceutical as a key component. The country has an objective in respect to the wider diversification of the medicine export profile given consideration to destination and products.

The global demand of exporting drugs has risen and so the nation is pushing its focus mainly on pharmaceuticals. By 2030, the pharma industry of India is hoping to become the largest drug supplier of the world. The target is to touch a revenue of approximately $120-130 billion at c CAGR of 11-12%. Presently, it is $38 billion.

Posing as world’s pharmacy:

Experts opine that this nation is posing as the world’s pharmacy due to the supply of low priced high-quality drugs in different countries. Medicine exporters in Qatar and other locations order drugs in bulk on a regular basis. The estimation of the government says that India proudly holds the 3rd rank globally for the production of pharmaceutical products by volume. Also, it holds 13th rank in pharmaceutical production by value.

Pharmaceuticals exporters in Africa: Now

According to an estimation, Africa spends approximately $2 billion per year on the treatment of AIDS patients. The executive director of UNAIDS, Michel Sidibé opined that if India would not help, then Africa could not access the treatment of AIDS at $2 billion. Without the presence of India, the cost could reach around $150 billion which is excessively massive.

Additionally, pharmaceutical exporters in Africa or pharma manufacturer in Nigeria are considering tuberculosis and anti-malaria drugs from India. The cost is much less than the medicines supplied by European and US drug suppliers.

In 2015, pharmaceutical exporters in Africa took pharma products that worth around $4 billion. Each year, the generic drug market in Africa is growing at 25 to 30 per cent. The market depends mainly on importing generic drugs.  Hence, the small, mid and good Indian pharmaceutical companies are grabbing this golden opportunity to expand the size and revenue.

Many times, the small pharmaceutical producers in India cannot match the stringent standards imposed by the authorities of Europe and the US. But, it is not the case with Africa, Nigeria, Tanzania, Madagascar, Mozambique, etc. So, the pharmaceutical companies in Nigeria, Africa, and etc. export bulk generic drugs and other pharma products from Indian companies.

Advantage India:

  • Among the top importers of pharma products from India, Nigeria, Qatar, Africa, Thailand, South Africa, USA, Russia, etc. hold prominent name.
  • Right now, generic medicine suppliers in India export around 20 to 22 percent of global export volume.
  • The cost of manufacturing is lower than half of Europe and the entire USA.

Indian pharma manufacturers and suppliers are helping relatively poorer nations like Africa, Nigeria, etc. to deal with tuberculosis, malaria, HIV, and other diseases like presently COVID issues through generic medicines that are low cost. The pharma manufacture in Nigeria is considering India as the key support to get the drugs in bulk for their people.

Thailand pharmaceutical manufacturers seeking India’s support:

Thailand is also wishing to get India’s support in the medical fields like pharmaceutical products and generic drugs. The top pharmaceutical companies in Thailand want to close the big gap between demand and supply of medical devices and pharmaceutical products. It is a major tourist spot. Besides, people from all over the world take treatments from here. India can efficiently fulfil the demands.

Ending with:

Pharma companies in Thailand or top 20 pharmaceutical companies in Nigeria, or any pharma manufacturers and exporters from other nations like Qatar, Africa, and others are depending on India for taking international brand names and generic medicines manufactured in this country. Certain awarded, accredited and trusted firms are ruling this field since long. These firms are committed to offering quality products to global clients.

They act as the one-stop solution for the entire pharmaceutical requirements without any compromise in quality and consistency. The WHO: GMP certified manufacturing plants ensure the products’ quality. The medicine exporters in Qatar, Thailand, Africa and other countries can easily contact these Indian firms online and discuss their requirements and objective. The private sectors and government of these countries are taking initiatives to strengthen the bond with India and exchange help. The authentic Indian firms are providing full value for money at each stage of pharmaceutical production and supply.

Medicine Manufacturer
pharmaceutical exporters

A Glance on the Improvement of Today’s Medicine Manufacturers Globally

The market of medicine is always profitable as the demand for medicines will be there as long as humans and animals will exist on earth. But, still there lie certain challenges as generic drugs are considered as cheap and low-quality replacement of branded drugs. Again, patients and doctors are doubtful about the efficacy and safety of these low-cost drugs.

A view on generic drugs:

Generic drugs are supposed to contain the exact active ingredients that are used in the branded formulations. FDA or the U.S. Food and Drug Administration allows identical generics or that are within a justifiable bioequivalent range of the branded counterparts embracing the pharmacodynamic and pharmacokinetic properties.

The top pharma companies that export such medicines and drugs need permission. Exporting controlled drugs such as stimulants, opioids, psychotropic substances, drugs used in lethal injections, etc. must get permission to export to other countries.

Since years, pharmaceutical medicine suppliers are working on various aspects to improve the services.

Steps were taken:

  • The modern pharmaceutical exports hubs are looking for effective ways to raise the marketability. Also, they are focusing on the positioning of their products. It will accelerate the number of release technology formulations that are controlled and entering the market. The companies dealing with drug formulation technology are jointly working with medicine manufacturers for defining the prescription formulations stepping in the preclinical development and furthering to a clinical trial.
  • Again, medicine exporters are ready to face challenges arising in the global pharmaceutical industry. The challenges include complex research aspects, certain developmental and regulatory conditions, fast-changing demands of customers, etc.
  • They are producing a wide range of therapeutic medicines. In fact, they are offering a vast array of dosage forms like controlled-release, injectables, oral solids, liquids, sterile, topicals, semi-solids, high-potency products, and transdermals.
  • They are not missing any opportunity and capitalizing each one of it. It is to deliver high-quality pharma products to a maximum number of pf people worldwide. With a synchronized supply chain augmenting the robust pharmaceuticals development capacity, unique manufacturing as well as vertical integration with Active pharmaceutical ingredients, the companies are creating an estimable track record of launches that are successful.
  • They are increasing the number of state-of-the-art facilities for producing non—sterile oral formulations, sterile powder formulations, APIs, etc. Also, they are building new PD labs and microbiological labs with high-tech equipment.

Other important aspects that prove pharma companies are improving:

Following the guidelines of Good Automated Manufacturing Practice, the top pharma medicine exporters are setting up a fully automated electronically controlled operating system. Besides, they are obeying international environmental, and health and safety regulations.

Actually, the medicine manufacturers and exporters are surpassing their own status and standards with quality assurance. They have an internal team of quality assurance that report directly to the highest regulatory bodies.

They have WHO-GMP certified manufacturing hubs. They are gracefully adopting modern methods including aqueous coating and packing tablets in combi-packs.

Improving quality control and meeting rising demands:

Today’s top-performing medicine manufacturers, for instance, JoinHub Pharma, are extremely focused on quality, complete compliance, 100% safety, and efficiency. The quality control laboratory ensures purity, safety and usefulness of all the products. The employment of highly capable researchers and medicine developers are bringing superior quality via continuous testing at production, packaging, storing, delivering, and exporting levels.

Besides, API analysis and other instruments such as finished products, packaging, relevant materials, etc. are taken care of.

The demands of the healthcare sector are ever-changing. The best pharma manufacturers are playing the crucial role of being the third-party medicine producer and helping the credited houses of Latin America, CIS, Africa, etc. Over 1000 formulations including soft gelatin tablets, powder, soap, injectables, etc. are produced and exported to different nations.

They are striving extremely hard to satisfy their clients from buying the best quality raw materials to dispatching the completed products. The most appreciated part is the unbeatable cost that is making it easier for the outsiders to become loyal customers.

Helping clients to promote business:

Exporting medicines to other countries require certain documents like Free Sales Certificate, COA, MOA, COO, and others. The top pharma companies keep these documents prepared to avoid any mishap during export. Again, nowadays, they are supporting their clients in promoting their business making use of marketing materials such as free samples and goods. Additionally, the companies are promoting sachets, ointments, suppositories, vials, syringe lotion, etc.

Almost all pharma segments for humans and animals are covered which involve generic medicine, hormonal therapy, oncology, innovative molecules, antibodies, and so on.

Execution of purchasing of raw materials, medicine manufacturing, research and development, quality control, medicine testing and packaging, shipping, and final delivery is given prime importance. The pharmaceutical medicine suppliers are maintaining ethics and standards in each step which is progressing them towards being better.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Pharmaceutical Exports
pharmaceutical exporters

Can Indian Pharmaceutical Exports Develop Post Corona Virus Chaos?

India is extremely cautious in resisting the transmissible spread of corona virus compared to other developed countries like the United States, China, etc. The nation is consistently restricting mobility from a foreign land, tracing contacts, executing lockdown, and so on. The top medicine exporter from India is making efforts to send necessary medicines including hydroxychloroquine to other countries.

India is in a better position in restricting the virus spread by taking all the precautions. The nation is experiencing lesser death. It has created ample opportunities for Indian pharmaceutical exports. The firms have achieved 15.3%in the financial year of 2020-21. Pharmaceuticals Export Council of India, Pharmexcil has opined that the Indian pharma export firms can reach the mark of $25 billion.

 

Pharmexcil’s view about Indian pharma exporters:

The director-general of Pharmexcil, Mr. R UdayBhaskar opined that generic formulations cover over 70% of pharma exports of India. The exports of pharmaceuticals in the financial year of 2019 and 20 reached $20.5 billion of which over 75% are generic formulations. Vaccines and APIS are also exported. Approximately $28 billion can be touched by FY22. The medicine manufacturers in India produce pharma products at a large scale.

 

Investment in the healthcare sector:

The investors are showing more interest in investing in other nations’ outward development of healthcare sectors. It is due to the present advantage of India with respect to pharmaceutical production. India is providing medical training and sending technical expertise to other nations where the healthcare system is not up to the mark.

In fact, many international NGOs and non-state actors dealing with public health are making use of generic drugs produced in India. The affordable cost of treatment is the primary reason behind it.

To take a few names, a humanitarian organization named Doctors without Borders has done an estimation concerning AIDS treatment with the use of generic drugs from India which is at least two to three times affordable compared to other brands of other developed nations. This is not the end as globally recognized organizations like UNITAID and UNICEF depend heavily on Indian generic drugs for various programs.

 

Indian pharmaceutical company has great potential for trading:

The pharmaceutical companies in India have greater potential in increasing trade partners domestically and internationally. The government is giving encouragement through investment in the research and development of the pharma sector in India. Medical colleges and universities are progressing in this regard. The Indian government is providing a large number of incentives to the private sector for increasing pharma production for the purpose of export.

 

Medicine manufacturers in India are successful in multiple ways:

India is undoubtedly growing as a pharmaceutical supplier. It has become the largest generic medicine provider in the whole world. The country is presently occupying approximately 20% share in the worldwide supply by volume. Indian medicine manufacturers are supplying 62% of the global demand for necessary vaccines.

Currently, India holds the 3rd rank globally for pharma production by volume. Also, the nation holds 14th rank for production by value. The largest number of pharma plant which is US-FDA compliant are located in this country. The number exceeds 262 which includes APIs.

Presently, India is blessed with:

  • 2000+ WHO-GMP approved pharmaceutical plants
  • 253 European Directorate of Quality Medicines approved plants
  • 60,000 generic brands covering 60 therapeutic categories
  • 500+ Active Pharmaceutical Ingredients or APIs

The API industry in India ranks 3rd in the world as it contributes 57% of APIs to WHO’s prequalified list.

 

Pharma company in India in post coronavirus world:

Though we are still being forayed by COVID 19, yet the consistent growth of the pharmaceutical medicine suppliers from India has shown a positive light on the development of the pharma industry. The whole world is giving attention to the evolution of healthcare right now to curb the current COVID 19 and upcoming horrors.

Global public goods including healthcare security is urging nations to look for partners with a competitive advantage in offering medical expertise for proper treatment, essential drugs, capacity building for in-state medical aids, offering medical service to other countries, etc.

 

Conclusion:

The top pharma companies in India are doing extremely well in the sphere of pharmaceutical exports and medical tourism. They are working very hard at meeting the fundamental aim of offering global clients with utmost flexibility, adaptation, and detailed focus on all the steps. The investors and clients using drugs manufactured by these pharmaceutical medical suppliers are getting the best return on investment.

Countries like UAE, Mali, Zimbabwe, Nigeria, Sri Lanka, Vietnam, Afghanistan, Kuwait, and many other nations are coming forward to import generic medicines, injectables, APIs, and other pharmaceutical products from India at a reasonable price. Therefore, medicine manufacturers in India need wide-ranging reorientation in the global commitments and priorities ranging from domestic and international channels.

Indian Pharmaceutical Company
Pharmaceutical Company

Investing in an Indian Pharmaceutical Company – A Profitable Deal

India is doing extremely well in the pharmaceutical industry for over a few decades. The basic reasons are the availability of affordable labor and raw materials in abundance. The top pharma companies in India are discovering new molecules and bringing new medicines on board to curb various diseases and pathogens making human and animals’ life better than ever.

Medicine manufacturers in India have become a blessing for the business holders and shareholders due to the world’s dependency on India for APIs and other types of medicines. India supplies over 50% of the vaccines of the world. The UK receives 40% of generic medicine and the UK obtains 2% of all medicines from this country. It leaves no doubt that the industry of pharmaceuticals is growing by leaps and bounds and many business holders are eyeing it to make a massive profit.

A statistical view of the Indian pharma industry:

India is a country to deliver the 2nd largest share of biotech and pharma labors to the entire world. 2019 has greeted Rs. 1.4 lakh crore of domestic pharma market turnovers. In 2018, it was Rs 1.29 which indicates there was a 9.8% increase in a single year. Indian pharmaceutical export companies have employed a huge number of employees in various departments to perfectly cater to the needs of manufacturing and export medicines to all other parts of the world.

The sales of pharma products reached 9% (Rs 10,342 crore) in this year’s May. Moving Annual Total based calculation depicts that in December 2019, the pharma industry was at a growth of 9.8% with a price hike of 5.3%, and a volume hike of 2% y-o-y.

New Indian pharmaceutical company is emerging:

The colossal growth of the pharma industry has urged many business holders to invest in it and hence, many new Indian pharmaceutical companies are starting their journey in the league. Over 200 countries throughout the world import pharma products from India paving the golden way for any medicine exporter from India to increase their activities.

India is considered the most substantial provider of generic medicines globally. It consistently maintains its supremacy in this field making itself a hope for the investors. Again, owing to the growing number of pathogens and various diseases, the top pharma companies in India are intensifying their research and development, and manufacturing medicines on a large scale. Some of the best medicine manufacturers in India, for instance, JoinHub Pharma and others, are commercializing innovative therapies to curb the patients’ suffering.

Moreover, the price is kept affordable so that people of all economical strata can purchase medicines and other pharma products. In fact, the companies are looking after the improvement of the Indian pharmaceutical exports to reach every corner of the world where medicines and injectables are needed.

Therefore, it leaves no doubt that medicine manufacturers in India are business people’s dream. By this year’s September, the country has exported a record worth of US$ 11.80 billion of pharma products. As per the statistical prediction, the medical devices industry is constantly growing by at least 15.2% annually and can come to US$ 25 billion by 2025.

Unquestionable development of pharmaceutical medicine suppliers:

The top pharma companies in India that manufacture, pack, and supply medicines are committed completely to acquire the right quality at a rapid speed. Plus, they adopt cost-effective procedures at each stage of development. These firms are experts in industrialization and make sure that the end products are okay for manufacturing and commercialization at a large scale. The stakeholders can save a lot of money and time by investing in these firms.

Infact, the Government of India (Department of Pharmaceuticals) has launched Pharma Vision 2020 with the conceptualization of making India a comprehensive drug discovery hub. Under Union Budget 2020-21, the Ministry of Health and Family Welfare has allocated Rs. 65,012 crore indicating massive development of this industry.

Again, the project managers of the high profile Indian pharmaceutical company are deeply concentrating on the needs of customers. The focus is also on the timely delivery of the drugs including tablets, injections, capsules, ointment, oral liquid, suspensions, external preparations cream, nasal drops, eye, and ear drops, etc.

Furthermore, the coronavirus has made it immensely necessary to have multivitamins and minerals supplement on a regular basis. The top-notch medicine manufacturers in India are keen on manufacturing multivitamins and minerals along with hand sanitizers and protective masks to stop the deadly virus from entering the body and attack the immune system.

 

Conclusion:

The pharma industry in India will touch $65 billion by the year 2024 as per prediction. Any accredited and certified Indian pharmaceutical company is actively involved in contract manufacturing drug intermediates and active pharma ingredients and is making an unparalleled track record in the international market. The current focus is more on pharma innovation backed by ground-breaking science. All these aspects result in a positive opportunity for the investors to invest in the top medicine manufacturers in India making the country become number 1 in the pharmaceutical industry.

Simply give us a call on +91 99793 82527 or drop us a mail at [email protected]

Pharmaceutical Distribution Company
Pharmaceutical Company

How to Start a Pharmaceutical Distribution Company

Do you know that the Indian pharma industry is the fourth biggest as far as volume is concerned? It is amongst the top 15 in the business worth worldwide ranking.

To become part of the essential journey of the pharma industry; one doesn’t have to set up a huge manufacturing unit that involves hefty investment. It is additionally possible to reap the advantages by launching a pharma distribution company which is a relatively low-cost business.

The process of starting a business isn’t very complex. Once understood well, one can deal with the procedure without hassles.

Who are these pharma distributors?

The pharma distributors are generally described as the middlemen between the drug manufacturing company and the retailers or the end-users. It is difficult to understand exactly how to begin the best pharmaceutical distribution company. However, here is the information you need in detail if you are the inexperienced one for your startup.

Legal requirements

The import, manufacturing, and distribution of drugs fall under the Drugs and Cosmetics Act, 1940. It has provisions for the categorization of drugs under different schedules. When one needs to launch the distribution business, a license must be issued from the CDSCO (Central Drug Standard Control Organization) or any similar state control body.

The individual applying for the license ought to have a degree or diploma in pharmacy from a recognized institute. There should be at least 1+ years’ experience in dealing with drugs.

GST Registration is required for launching the distribution business.

Documentation requirements:

  • Application form (in the prescribed format)
  • Covering letter with name and designation of the candidate
  • Declaration form (in the prescribed format)
  • Copy of the challan issued after submitting the fee for drug license
  • The site and key plan (outline) of the premises
  • Incorporation certificate, MOR/AOA, or partnership deed to state the constitution of the business
  • Evidence for possession (rent agreement, registration, or lease agreement)
  • Affidavit of non-conviction of chief or partners or owner
  • Affidavit for a full-time appointment of an enlisted drug pharmacist or equivalent resource

Pharmacy Inspector performs a regular assessment, and the business ought to satisfy all the norms laid by the authorities. Failing this, there is a chance of canceling the registration.

The apt space is essential for a pharma distribution company

When an application is submitted for starting a distribution organization, it is mandatory to furnish verifiable evidence of premises where the business will happen.

There must be vital infrastructure (storing and refrigeration facilities, rodent-free premises, hygiene, etc.) to protect the medicines.

Successful Business plan

Draft a business plan. It must be a savvy plan that makes the chances of success better. Do thorough research to comprehend your competitors. Assess the expenses needed to begin the company.

You should establish the organization’s structure, roles, and responsibilities. Recruit a staff of qualified and enthusiastic employees.

SWOT Analysis

Perform a SWOT analysis to comprehend the strengths and weaknesses of the proposed model.  It is similarly important to know the chances and threats. This would assist you with having an extraordinary overview of the market situation and how you can fit into it

Establish your brand in the market

Once the organization is established, it is time to promote the brand by utilizing every possible channel. It seems like a herculean task; however, it isn’t if you do it systematically.  Do the research well and put resources in marketing and advertising. Hire professionals and outsource the work. Every pharma companies know that being pharma wholesalers or pharma distributors and setting up the pharmaceutical distribution company in India and again getting the consideration from the audience is a truly difficult task. However if done once, you’ll be a successful brand in the market of pharma. By investing in marketing and advertising, you will be one bit closer to success. What you can do is get the marketing and advertising agencies on board. They can assist you with making all you required to make your brand name in the market.

This can include:

  • Logo
  • Brand image
  • Company’s goal
  • Website
  • And a marketing campaign

Budget is a must. The more you spend money, the more you will get promoted and get a return.

Finally,

This blog explains the process of starting a pharma distribution organization and taking it ahead of others. Taking the right steps, picking the right equipment, and recruiting the right team are the steps that can assist you with staying on the path of success.

JoinHub Pharma is leading manufacturers of Pharma Products that holds rich expertise as PCD Pharma Company in Ahmedabad, Gujarat, India. If you’re looking for wholesale pharma medicines then feel free to reach out to us anytime.

Simply give us a call on +91 99793 82527 or drop us a line at [email protected]

Pharmaceutical wholesalers
pharmaceutical exporters

Advantages of Purchasing Medicines from Pharmaceutical Wholesalers

With modern fast-paced life, the world is as of now facing significant health issues. Whether chronic illnesses or day-to-day ailments, the occurrence of illness is growing dramatically. Therefore, the demand for medicines is always high in the market.

However, a lot of duplicities are occurring in the pharma industry nowadays. A few retailers are selling fake medicines or hiking the prices to increase their revenues.

Henceforth, like a hospital or an independent pharmacist, it becomes important to take time before buying the medicines. To grow your pharma enterprise, you may require a variety of authentic products at reasonable prices. You additionally need an on-time supply of these items, to keep meeting the market demands.

This is where the pharmaceutical wholesalers step in. The supply of the bulk of quality products from these wholesalers can to a great extent simplify your business. Here are a couple of benefits of purchasing medicine from a pharmaceutical wholesaler:

Variety & Convenience

Are you someone who needs to jump from one store to another to find medicines at wholesale rates? The pharmaceutical wholesalers will in general stock their shops with various sorts of drugs under the same roof. This makes your task easier and saves a lot of your time. With various types of drugs in their stores, you can be assured to address each consumer’s needs.

Valuable Industrial Information

The pharmaceutical market is ever-changing. If you haven’t noticed this, then you have missed the most important update. Best pharmaceutical companies can help you with the most important information on the major changes that are probably going to affect the pharmaceutical industry.

This will empower you to make prior arrangements on your purchasing plans. For instance, if there are chances of price hikes, then you can purchase the drugs in advance.

Most Affordable Prices

The facts confirm that healthcare is quite expensive for most pharmaceutical suppliers and consumers. Along these lines, if you want to reduce expenses, you ought to surely buy drugs from wholesalers. As they sell their goods in bulk, they ensure economies of scale.

Particularly, the Indian wholesale suppliers set high standards when it comes to reasonableness. These wholesalers work together with the retailer to cater to worldwide needs. India has the highest number of US FDA approved pharma companies, which guarantees trust. The superior quality of affordable generic medicines in India is unmatched, and you should exploit to grow your business.

Room for Negotiation

Wholesalers typically throw in a discount or two to pharmacists who purchase their products regularly. Furthermore, if you are able to build a decent relationship with them, they additionally sell medicine and other items at a much lower cost.

This advantages the top pharma companies as well because they can hold their old customers to guarantee adequate business scopes. Consequently, it creates a win-win situation for both parties and you should definitely take advantage.

Deliveries

With wholesalers, you don’t have to actually go to their shop and get your medicines. Most of them offer the delivery of the products to the door. They may charge some additional fees for that, yet it is far cheaper than actually going to their place and purchasing your products.

This feature is especially helpful for cross country trades. Indeed, Indian pharmaceutical exporters can offer you one of the best export services paired with their top-notch pharma products.

How to Choose the Best Pharmaceutical Wholesaler

Since you know the advantages of pharmaceutical wholesalers, you should likewise know how to choose the right wholesaler for your business.

If you simply browse the internet, you will come across many pharmaceutical organizations that guarantee to offer the best services. But, are all these claims genuine?

Well, actually not. On the of the chance that you neglect to do your bit of research and choose the wrong company, and then you may endure significant losses. Here are a couple of things you should keep in mind while picking the right pharmaceutical wholesaler:

Know the services that they provide

You should know about all the services that these organizations offer. You should likewise know the countries they serve and the product categories they offer. For instance, JoinHub Pharma serves more than 50 countries, which include Gulf countries, South Africa, and Asia.

Check the reliability of the company

Authenticity and rich experience matter a lot in the pharma industry. Make sure that the organization has worked with the right clients and has enough insights, before associating with them. Additionally, try to contact their previous customers (if possible) and get their feedback.

Product Quality

Obviously, the company should be certified by reputed organizations, so that you can trust them with their quality. JoinHub pharma is certified by WHO, WHO-GMP, US FDA, and ISO 9001.

Delivery

Ensure that the pharmaceutical wholesaler delivers your orders on-time. Defaults have no place with regard to the pharma industry.

Contacts and Connections

An ideal wholesaler ought to have associated with multiple pharmaceutical manufacturers. This will empower the company to satisfy all the demands of their customers. Far and away superior if the company has its own manufacturing unit. For instance, JoinHub Pharma has its world-class manufacturing facility located in Gujarat, India

Reach out to JoinHub Pharma – A leading pharmaceutical company in India. Our representatives are just a call away. So don’t hesitate, call us today!

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

hand-sanitizer
Hand Sanitizer Manufacturer

Does Hand Sanitizer Work?

With the coronavirus (COVID-19) outbreak, it’s not astounding that many people are finding ways to stay safe, including stocking up on sanitizing sprays, gels, and soaps.

In any case, hand sanitizers give a convenient and compelling way to clean your hands if soap and water aren’t effectively accessible and your hands aren’t covered in visible dirt or grease. According to the 2019 decision by the FDA, hand sanitizer suppliers can advertise a product as a hand sanitizer if it contains ethyl alcohol, isopropyl alcohol (isopropanol), or benzalkonium chloride as the active ingredient.

The FDA hasn’t settled a choice on whether to categorize those three ingredients as “generally recognized as safe” since the organization doesn’t think there is adequate research to say. But at the same time, they’re not pulling the items from shelves. Ingredients other than those three have demonstrated little to no proof of being viable at killing germs and have not won the FDA’s endorsement.

How does it work?

It is executed by killing cells—not human cells. It also kills microbial cells. It depends on the utilization of 70% isopropyl alcohol, which is rubbing alcohol. That is the concentration of rubbing alcohol that is best in killing germs—it’s significantly more viable than 100%. Since it has a little bit of water in it, it enhances penetration. For infection, the best hand sanitizers work by disrupting the virus’s external coat. For a bacterium, they work by disrupting its cell film. It’s anything but a panacea, however, since certain infections lacking an outer coat (like the one that causes cruise ship diarrhea) or spore-forming microbes are not entirely defenseless.

How to Use It

When hand sanitizers accomplish work, their viability depends on several elements. Besides, to which item you use, they include:

  • How much you using
  • Appropriate procedure
  • Consistency

A few circumstances wherein utilization of a hand sanitizer might be appropriate to incorporate when you’re traveling in public transportation, have shaken hands, or contacted an animal after you’ve touched a grocery cart, etc.

To use hand sanitizer correctly
  • Put the suggested amount in the palm of one hand. (Read the manufacturer’s rules and directions.)
  • Rub your hands together including between your fingers.
  • Stop rubbing the sanitizer once your skin is dry.
Can hand sanitizer protect you from viruses?

Hand sanitizers with alcohol can prevent you from diseases– both viral and bacterial — when utilized correctly and in the correct scenarios. This implies applying a hand sanitizer that is at any rate 60% alcohol, utilizing the directed amount (read the label), focusing it in totally, and hanging tight for it to dry.

Hand sanitizer in coronavirus is suggested for use by medical care experts in clinical settings, as it’s been shown to decrease the spread of various hospital-borne bacteria and infections, including Methicillin-resistant Staphylococcus aureus (MRSA), which is viewed as a superbug.

Are all hand sanitizers created equal?

It’s essential to ensure any hand sanitizer you do utilize contains at least 60% alcohol.

Studies have likewise discovered that hand sanitizers with lower focused or non-alcohol-based hand sanitizers are not as successful at killing bacterias and germs as compared to those with 60 to 95% alcohol.

Specifically, non-alcohol-based sanitizers may not function admirably on various types of germs and could make a few germs to develop protection from the sanitizer.

Does hand sanitizer expire?

Hand sanitizer doesn’t generally expire. There will probably be an expiration date on the bottle since hand sanitizers are regulated by the FDA, which needs certain things to be on the packaging, including an expiration date. The expiration date should be the last date at which the item contains the ingredients in the amount determined on the label. Regardless of whether the hand sanitizer manufacturer has tried how long the product meets the label claim or they just came up with an arbitrary date to decide the expiration date is generally not known to consumers. (Manufacturers should direct testing, yet not all do.)

Alcohol is a shelf-stable chemical as indicated by its safety data sheet. This implies that if alcohol is kept in a sealed container at room temperature it will stay at a similar concentration for an incredibly, long time.

Be that as it may, the alcohol evaporates effectively due to its generally low boiling point, and after some time, as the bottle is opened and closed, some alcohol may getaway and the concentration of alcohol in your hand sanitizer may begin to diminish. In any case, if you keep the container closed and at room temperature, you’re probably going to have a successful item for as long you need it.

Is hand sanitizer bad for you or toxic?

Alcohols are considered to be safe for usage. It has generally no harmful effect on the skin, albeit repeated use may cause mild irritation and dryness, as per the Hazardous Substances Database. A few examinations have indicated that repeated utilization of hand sanitizer is less irritating than repeated handwashing with soap. Yet, damaged skin is more vulnerable to irritation from alcohol.

Get in touch with JoinHub Pharma – A leading hand sanitizer supplier.

We ensure that your hands stay germ-free for over long hours. Wellness and hygiene have turned out to be the need of the hour. With so many individuals realizing the need for cleanliness and healthiness, hand sanitizers in India are looked upon as a miracle product. We are a young and dynamic group of professionals based in Ahmedabad, India, and are committed to creating superior customer value by providing total scientific solutions to existing and emerging consumer needs in the health & personal care category.

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

pharma-exporters
pharmaceutical exporters

Pharma Exports from India – Key Trends and Predictions

India is known as the “pharmacy of the world”, and the biggest generic drug provider in the global market. The exports from the nation include drug formulations, herbal products, bulk drugs, surgical, intermediaries, biologicals, and Ayush. Over half of the global demands for various vaccines, nearly 40% of US demands for generics, and 25% of UK demands for all pharmaceuticals are provided by India.

Over the years, pharma exports from India have made huge progress in the worldwide markets. The nation’s potentially skilled scientists, engineers, and dedicated workforce are the motivation to gear this industry to profits. The current statistics depict that India gives over 80% of the antiretroviral drugs utilized worldwide to fight AIDS.

Key Trends and Predictions:

Based on the on-going benefits and predictions globally, by 2025 the pharma sector of India is anticipated to rise to $ 100 billion, while the market for a medical device is projected to increase to $ 25 billion. On a similar note, the nation’s biotechnology industry that includes bio-industry, bio-agriculture, biopharma, bio-services, bioinformatics is required to increase at an average growth rate of over 30% every year, such that rising to $ 100 billion by 2025.

There were changes made to the current FDI policy in the pharma sector endorsed by the Union Cabinet, wherein up to 100% FDI is permitted in the manufacturing of medical devices for specific diseases.

Low-cost manufacturing of generics, medical devices, intermediaries, supplements, and numerous other pharmaceutical exporters in India have drawn in many foreign investments to set up new manufacturing plants. This has prompted a consistent growth in the nation’s revenue production. Backing the plan, the industry has additionally gained consistent support from the government as it generates employment and contributes to the nation’s GDP.

 

A couple of the initiatives taken by the government in support of the above are:

    • According to the 2019-2020 economic survey, the government expenditure on health (wrt. GDP) flooded by 1.6% in FY20 as compared to 1.2% in FY15
    • Almost $ 1.3 billion funds will be invested in organizations for domestic manufacturing of pharma ingredients by 2023
    • The government has designated $ 4.88 billion for the National Health Mission beneficial to offer better medical access to urban and rural people
    • Under the Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), the government apportioned $ 915.72 million for the medical insurance scheme
    • According to the declaration made in the Union Budget or 2018-2019, The National Health Protection Scheme is the biggest government healthcare program in the world, is projected to grant a cover-up of up to Rs. 5 lakhs per family/year to get secondary & tertiary hospitalization care, profiting 100 million poor families in India
    • The National Digital Health Mission is accepted to set policies for pharmaceutical products in India available in the online market to annihilate misuse of medications and drugs
    • Aiming to platform India as the worldwide pioneer for end-to-end manufacturing of pharmaceuticals, the government of India uncovered the ‘Pharma Vision of 2020.’
Strengths of the Indian Pharmaceutical Exports

The country has one of the most minimal expenses of manufacturing and is one of the fastest-growing.

The increasing support from the government for the pharmaceutical industry and a consistent rate of growth in incomes are all working in favor of the pharma business.

There are 4 key competitive benefits of the Indian pharmaceutical industry include:

  1. Availability of raw material
  2. Low cost of innovation
  3. Extensive Distribution Network
  4. Skilled workforce

India has gifted experts and pharma professionals who are capable of the English language. This helps in the minimal effort of innovation, manufacturing compliance, and documentation.

The Generic Advantage

Indian pharmaceutical organizations fundamentally cater to the generic drug market. The primary focus of pharmaceutical exporters in India includes:

  1. Generic Drugs
  2. OTCs
  3. Patented Drugs
  4. Active Pharmaceutical Ingredients
  5. Biosimilars

India is among the biggest exporters of generic drugs universally. As per FactSet, the total Indian Research investment in generic drugs expanded by 3.8% of sales in 2010 to $12.55 billion.

 

Opportunities

 Latin America: An Opportunity for Indian Pharmaceutical Logistics

A report by financial express features some key facts and opportunities for Indian pharmaceutical exporters in the Latin American market:

In 2015 Indian exports to Latin America reached to $1063 million crossing $1billion with country-wise

Indian pharmaceutical exports to Latin America comprised 7.7% of the total in the year 2014-15. Off late, the trend in exports to Latin America has moved from bulk drugs (APIs) to the completed product.

Venezuela and Brazil are some of the vital business sectors for finished formulations while Mexico has a solid demand for bulk drugs. Latin America is additionally a rising market for Ayurvedic products – an opportunity for Indian exporters to tap.

 

The West African Market

The majority of the Indian pharmaceutical exporters see a growth opportunity in the West African market. As indicated by Mckinsey, the size of Africa’s pharmaceutical market reached $20.8 billion in 2013 when contrasted with 10 years sooner.

The survey anticipates that the size of this market will grow to become $40 – $65 billion – by the year 2020. The study estimates predictable growth in demand for prescription drugs, over the counter devices, and medicines. The report underlines the economic and infrastructure growth of African cities while likewise shows the growing activities in the healthcare sector like:

  1. Growth in the number of hospital beds and healthcare experts
  2. Government guideline and price control on medications

The study likewise proposes that local partnerships with organizations, NGOs, and governmental bodies would assist Indian pharmaceutical players to tap the growing business opportunity.

Moving forward, a few steps have been taken to decrease the cost of healthcare access for the public. The Indian government has been keen on drawing in top organizations across the world to align pharma products with the growing rate of chronic diseases, just to generate domestic sales.

Reach out to JoinHub Pharma – A leading pharmaceutical company with expertise in manufacturing high-quality, affordable generic, and branded medications.

 

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

generic Indian drugs
Generic Medicine

How COVID-19 Open up Opportunities for India’s Pharma Industry that Must Be Seized

Given the magnitude of the COVID pandemic and its spread across the world, it seems to be almost certain by now how a post-coronavirus world will observe an altogether different ordering of the worldwide economic and political system of commitments and preferences.

If the Great Recession of 2008 united numerous nations in guaranteeing collective banking and financial sector reforms – to save an infectious spread in the financial sector – the 2020 worldwide pandemic shall ideally make the global commitments and needs of most nations more skewed towards guaranteeing more prominent public health security for its citizenry.

Up until this point, as the crisis is still unfolding, many critical multilateral arrangements in place – regardless of whether the G20 or G7 – have played a limited role in introducing a unified front or in reassuring and giving effective measures of relief to most affected nations.

The G2 ‘Great Powers Club’ too for example US and China, have confronted criticism for showing weak global leadership, as the pandemic has infected one country after another.

 

But what about India?

In comparison to other countries, say, China, Eurozone, or the United States, India has been both fortunate and cautious, in preventing the infectious spread of the virus in its domestic territory with early restrictions on mobility from different countries, seeking contact tracing, and declaring a lockdown early. It has likewise taken larger efforts as of late to send across medical supplies and drugs (including hydroxychloroquine) to different countries in need.

Assuming that the country takes all the important precautions ahead and keeps the infection curve trajectory more flattened, India has a decent opportunity to come out on the better side of the crisis. What’s more, that offers India a window of opportunity in this emergency.

So, how would India be able to utilize this crisis as an opportunity to reorder its own worldwide commitments and rise as a significant actor to permit more nations to become interdependent and associate with a huge developing market?

In a post-coronavirus global order, India’s similar favorable position can depend intensely on becoming a significant provider for global public goods and services, given how the demand for these are probably going to go up in years to come.

Here, we talk about the prospects in healthcare as a case in point.

India’s current preferred position of large-scale pharmaceutical production enables it to significantly leverage its soft power by investing in the outward growth of the healthcare sectors of different nations by:

  • Ramping up exports in drugs;
  • Turning into a preferred medical tourist destination for those looking for affordable treatment in quality secondary/tertiary health services,
  • Seek after medical diplomacy by offering medical training and technical expertise to many other developing nations whose healthcare systems are a lot worse than India.

 

Boosting pharma exports

As per the Indian Brand Equity Foundation (IBEF), pharmaceutical exports of India from the financial year 2012 to 2019 have consistently grown from $10 billion to $19 billion.

According to estimates, India represents about 10% of the world’s pharmaceutical production by volume and 1.5% by value. The industry is the world’s biggest supplier of generic drugs and controls around 18% of the worldwide market. It is additionally a leading producer of vaccines on the planet and caters to about 50% of worldwide vaccine demands.

This is because of the effective high demand for Indian drugs in light of cheaper pricing, making these more reasonable to both developing and developed nations.

Indeed, even with the breakout of the COVID-19 pandemic, many private Indian pharma manufacturers expressed their desire to expand their supply of required medications– like hydroxychloroquine – to these nations.

Not only states, however public health non-state actors and many international NGOs have been utilizing generic Indian drugs for affordable treatment in countries within Africa, parts of Latin America over the last decade.

 

Empowering medical tourism in India

Over the last few years, especially since 2014, the number of people coming to India for medical treatment has grown yearly at about 55%. As per the Ministry of Tourism, the medical tourism space was estimated at around $3 billion (US$) in 2015 and at $9 billion in 2020.

The Indian government has additionally advertised India as a superior medical tourist destination by giving fast-track medical visas and rapid airport clearances for those visiting as medical tourists. Although, most vital players in the medical tourism space are those in the private sector yet obviously it is clear that this is a space for the Indian government to develop significantly more capacity in years ahead.

 

Pursue medical diplomacy

In spite of India’s colossal steps in medical-value tourism and in the growth of pharmaceutical exports, it actually has a long road ahead to use its potential at a worldwide level. India’s own public-healthcare system appears in poor shape (excepting some of the states in the Southern and North-Eastern part of the nation). It has one of the most minimal doctor-to-population ratios in the world. The gains accrued have to a great extent been due to the asymmetric, privatized nature of the healthcare system in India-which has permitted the private sector to make inroads to other local/and global accomplices (in West Asia).

To project itself as a nation practicing medical diplomacy through soft-power, if there is one nation from which the Indian state can especially learn, is Cuba.

Regardless of being a small nation with a much lower per-capita income, Cuba’s public healthcare system is truly outstanding in the world. The Cuban State has polished a humanitarian goal of medical-internalization as a major aspect of its diplomatic mission and acquired a more extensive reputation and praise by offering doctors and medicines at times of health-emergencies in many nations in need. Its medical teams -sent in the state, have likewise maintained a longer presence in health emergencies prone areas around the globe with around 50000 doctors stationed abroad by 2018. In the recent past too, Cuba sent the biggest group of medical doctors to West Africa during the Ebola epidemic.

The communist state additionally embraced a diplomatic strategy of making bilateral agreements with countries like Argentina and Venezuela, to pay for offered medical services, while likewise guaranteeing medical aid to nations like Algeria and Haiti in times of war and different crises. Thus, this arrangement by the year 2018 brought about $11 billion in (medical) exports from Cuba while additionally financing its helpful efforts.

In a post-coronavirus world, healthcare would rise as a significant point of attention for some countries over the world. What’s more, in a reordered version of globalization, worldwide public goods like healthcare security will attract countries to look for partners with a more comparative advantage in providing for medical expertise for treatment, essential medications; and in-state capacity-building for medical-aid and service to different countries (as needed).

India can possibly do tremendously well in the first two of these areas (given its similar advantages in pharma-based exports and in medical tourism), for the third, in embedding state-diplomacy with medical-diplomacy and putting resources into its outreach, there should be a radical (re)orientation in our worldwide (diplomatic) priorities and duties, starting from territorial to international channels.

We at JoinHub Pharma – the leading pharmaceutical company in India manufacture high-quality, affordable branded and generic medicines. Contact us to discuss more pharma products.

 

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Generic Pharmaceutical Drugs
Generic Medicine Pharmaceutical Company

Do Generic Pharmaceutical Drugs Compromise on Quality?

Nowadays due to increased health problems, and high medicinal expenses people have started making a shift to generic drugs which are the same as brand-name drugs and offer almost equivalent medicinal properties. Generic pharmaceutical companies have never been as famous as branded and marketed drug companies. So people always have a question regarding are generic drugs as safe as their branded counterparts and are they effective in treatments for severe health implications.

Generic drugs are identical counterparts of branded drugs and medicines manufactured by large corporations. When the patent of any particular brand-name drug expires, other smaller pharmaceutical companies manufacture a generic version of it and sell it in the open market. Generic drugs are relatively cheaper as the companies producing it do not have to invest much time and money into the research and development stage. Because a formulation is already available, everything the company then needs is just to manufacture it and get it approved by the FDA.

How does the FDA approve Generic Medicines?
If a company wants to get its generic drug approved with the FDA’s stamp, it must manufacture a drug that can be seen as a bioequivalent of the brand-name drug previously available. The FDA allows drug manufacturers to make a change in the active ingredients of medicine for up to 20% but top generic pharmaceutical companies do not go to that extent in making changes in the drug’s composition.

Moreover, generic manufacturers also do not need to go under vigorous drug tests as the data available with the FDA for previously used brand-name drugs is used as a result. Hence generic drugs are mostly passed with smaller test cycles and datasets. This does not raise a question about the effectiveness of the drug. The FDA chooses this course just to ensure that the drugs reach the patients speedily in the market.

Are generic drugs less effective?
Generic medicines are as effective as their brand-name substitutes. The FDA ensures that every drug being sold in the market is safe and effective for its consumers whether it is a brand-name drug or a generic drug. As we know generic drugs have almost identical medical formulation and are made using the same active ingredients used in the making of branded drugs, generic drugs are hence the effective and alternative solution to most branded drugs.

Generic drugs are also tested and reviewed thoroughly almost as same as their branded counterparts; hence consumers should not be worried about the drug’s effectiveness. The FDA also saves and publishes information regarding generic drugs for almost all types of critical diseases. Some people also think that generic drugs are cheaper as they are made by smaller companies with limited on-site production facilities but in contrast, the FDA makes sure that a generic drug manufacturing unit complies with all the norms laid down by the FDA for manufacturing of medicines and drugs. It isn’t always that only smaller companies manufacture generic drugs and sell them in the market, but research shows that almost 50% of all generic drugs manufactured come from big branded companies as companies always thrive to make their medicines available to consumers on a large scale.

How to identify Generic Drugs?
Some laws suggest guidelines for generic drugs; any generic drug cannot be made to look the same as its branded counterpart. However, differentiating between a brand-name drug and a generic drug is never a big hassle. Manufacturers, to comply with the statutory guidelines laid down by the FDA and other institutions; develop generic drugs that vary in packaging, naming, colors, shapes, sizes, and many more different dimensions.

Is a Generic Drug available for every other Branded Drug?
Branded drugs have patent protection for 20 years, which provides relief to a company that no other manufacturer can make the same drug and sell it in the market. However when a patent for a branded drug has expired or is about to expire other manufacturers can get consent from the FDA and start manufacturing the drug under the prescribed guidelines for generic drug manufacturing. It is somehow difficult to find generic drugs for brand medications that have been in the market for less than 20 years, as it comes under patent protection. However, a similar medication can be found if needed.

The Market’s Boom for Generic Drugs

Today numerous ailments have drugs with their prices sky-rocketing by the passage of time. Several insurance providers now approve and pay their insurance holders for opting into generic drugs. Generic drugs have now gained a higher level of trust from people and people consider them an effective option to switch from branded medicines. This has helped the generic drugs market to grow on a rapid scale for the last few years.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

CALL ME BACK